Skip to main content
logo
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.73
-0.25 (-1.79%)
Jan 8, 2026, 3:01 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Novel Immunotherapies
10.59M
Log In
Log In
Log In
Novel Immunotherapies Growth
30.99%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
10.59M
Log In
Log In
Log In
United States Growth
30.99%
Log In
Log In
Log In